WO2002069893A3 - Treatment of neurological disease - Google Patents

Treatment of neurological disease Download PDF

Info

Publication number
WO2002069893A3
WO2002069893A3 PCT/US2002/006108 US0206108W WO02069893A3 WO 2002069893 A3 WO2002069893 A3 WO 2002069893A3 US 0206108 W US0206108 W US 0206108W WO 02069893 A3 WO02069893 A3 WO 02069893A3
Authority
WO
WIPO (PCT)
Prior art keywords
cerebrospinal
flow
pathway
fluid
catheter
Prior art date
Application number
PCT/US2002/006108
Other languages
French (fr)
Other versions
WO2002069893A2 (en
Inventor
David P Hesson
Timothy J Pelura
Glenn D Frazer
Original Assignee
Neuron Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuron Therapeutics Inc filed Critical Neuron Therapeutics Inc
Priority to AU2002242293A priority Critical patent/AU2002242293A1/en
Publication of WO2002069893A2 publication Critical patent/WO2002069893A2/en
Publication of WO2002069893A3 publication Critical patent/WO2002069893A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Provided is, among other things, a method of treating in an animal infection or neoplasm of cerebrospinal tissue characterized by a risk of death, the method comprising: (a) injecting a physiologically acceptable fluid for cerebrospinal perfusion into a first catheter into the cerebrospinal pathway, which fluid for cerebrospinal perfusion has an therapeutically effective amount an agent, the agent selected for effectiveness against the infection as identified or diagnosed; (b) withdrawing fluid at a second catheter into the cerebrospinal pathway to create a flow and flow pathway between the first and second catheters; and (c) maintaining the flow for a period of time adapted to perfuse at least 1 CSF volume.
PCT/US2002/006108 2001-03-02 2002-02-28 Treatment of neurological disease WO2002069893A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002242293A AU2002242293A1 (en) 2001-03-02 2002-02-28 Treatment of neurological disease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79877401A 2001-03-02 2001-03-02
US09/798,774 2001-03-02

Publications (2)

Publication Number Publication Date
WO2002069893A2 WO2002069893A2 (en) 2002-09-12
WO2002069893A3 true WO2002069893A3 (en) 2005-05-19

Family

ID=25174232

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/006108 WO2002069893A2 (en) 2001-03-02 2002-02-28 Treatment of neurological disease

Country Status (2)

Country Link
AU (1) AU2002242293A1 (en)
WO (1) WO2002069893A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2589387A1 (en) * 2011-11-04 2013-05-08 Lunamed AG Use of a teichoic acid for the treatment of malignant liquor cerebrospinalis in the brain
KR102190915B1 (en) * 2018-08-31 2020-12-15 씨제이제일제당 주식회사 An adhesive composition, and preparing method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613324A (en) * 1985-06-17 1986-09-23 Ghajar Jamshid B G Method and apparatus for guiding catheter into ventricular system of human brain
US5624704A (en) * 1995-04-24 1997-04-29 Baylor College Of Medicine Antimicrobial impregnated catheters and other medical implants and method for impregnating catheters and other medical implants with an antimicrobial agent
US5800402A (en) * 1993-03-19 1998-09-01 Venetec International, Inc. Catheter anchoring system and method of use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613324A (en) * 1985-06-17 1986-09-23 Ghajar Jamshid B G Method and apparatus for guiding catheter into ventricular system of human brain
US5800402A (en) * 1993-03-19 1998-09-01 Venetec International, Inc. Catheter anchoring system and method of use
US5624704A (en) * 1995-04-24 1997-04-29 Baylor College Of Medicine Antimicrobial impregnated catheters and other medical implants and method for impregnating catheters and other medical implants with an antimicrobial agent

Also Published As

Publication number Publication date
AU2002242293A1 (en) 2002-09-19
WO2002069893A2 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
ES2456946T3 (en) Antimicrobial blocking solutions comprising taurinamide, derivatives, and biologically acceptable salts and acids, with the addition of low heparin concentrations
EA200000468A1 (en) THERAPEUTIC COMPOSITION FOR THE ADMINISTRATION OF TOLTERODINE WITH CONTROLLED DELIVERY
BR9610869A (en) Catheter specially designed to be placed in a body cavity for peritoneal dialysis
DE60134654D1 (en) LIQUID LIQUID DEVICE FOR TREATING THE HYDROCEPHALUS
EP1327454A3 (en) Method of treatment with medical agents
ATE276783T1 (en) CLOTT-RESISTANT MULTIPLE-LUMEN CATHETER
WO2000051623A3 (en) Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions
DE60133410D1 (en) MICRO CATHETER AND GUIDANCE WIRE SYSTEM WITH IMPROVED DURABILITY AND CONTROL
ATE198162T1 (en) DEVICE FOR TREATING HYDROCEPHALUS
WO2000076390A3 (en) Methods and low profile apparatus for reducing embolization during treatment of carotid artery disease
ATE36961T1 (en) DEVICE WITH A VARIABLE IMPEDANCE FILTER FOR THE TREATMENT OF HYDROCEPHALUS.
WO2004075948A3 (en) A method and catheter system applicable to acute renal failure
WO2003092617A3 (en) Combinations for the treatment of inflammatory skin disorders
WO2003034996A3 (en) Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
ES2177620T3 (en) USE OF AN INOSITOTRIFOSPHATE ESTER FOR THE TREATMENT OF INFLAMMATORY DISORDERS.
WO2002069893A3 (en) Treatment of neurological disease
WO2003097050A3 (en) A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
PL354961A1 (en) Prevention and treatment of diseases associated with blood coagulation
Usui et al. Cerebral metabolism and function during normothermic retrograde cerebral perfusion
CN101160050A (en) Method and kit for controlling bleeding
BR0213633A (en) Method and compound for treating a disease associated with aberrant leukocyte recruitment and / or activation
WO2002076400A3 (en) Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
WO2002067851A3 (en) Method for treating fibrotic diseases or other indications iiic
Frimodt‐Møller et al. Amifloxacin distribution in the dog prostate
Leuvenink et al. Effective streptokinase treatment of blocked catheters in pigs and sheep

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002707924

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2002707924

Country of ref document: EP

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)